SCHEMBL8428611

SCHEMBL8428611

CNc1ccc2c3c1C(c1ccc(Cl)cc1)=C2C(C)=C3Cc1nnn[nH]1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8430715 0.88 IKBKB (0.32)
SCHEMBL8430781 0.86 IKBKB (0.33)
SCHEMBL8428371 0.84 MAPT (0.39)
SCHEMBL8428466 0.74 MAPT (0.36)
SCHEMBL8432130 0.73 PDE4B (0.37)
SCHEMBL8428336 0.72 GCGR (0.31)
SCHEMBL8428247 0.69 KMT2A (0.36)
SCHEMBL6505678 0.66 NR1H2 (0.41)
SCHEMBL8428327 0.65 PDE4B (0.38)
SCHEMBL8428613 0.65 RXRA (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5965619-A ADMINISTERING AN INDENE DERIVATIVE OF GIVEN FORMULA, SUCH AS 1-(2,4,6-TRIMETHOXYBENZYLIDENE)-5-DIMETHYLAMINO-2-METHYL-3-INDENYL ACETIC ACID, TO TREAT PRECANCEROUS LESIONS SUCH AS COLONIC ADENOMATOUS POLYPS; SIDE EFFECT REDUCTION CELL PATHWAYS INC. (US) 1999-10-12 US disclosed